Episurf Medical Ab Stock Short Ratio
| EPIS-B Stock | SEK 0.15 0.01 7.14% |
Episurf Medical AB fundamentals help investors to digest information that contributes to Episurf Medical's financial success or failures. It also enables traders to predict the movement of Episurf Stock. The fundamental analysis module provides a way to measure Episurf Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Episurf Medical stock.
Episurf |
Episurf Medical AB Company Short Ratio Analysis
Episurf Medical's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Episurf Medical AB has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The short ratio for all Sweden stocks is 100.0% higher than that of the company.
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Episurf Fundamentals
| Return On Equity | -0.45 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (11.71) % | |||
| Current Valuation | 291.48 M | |||
| Shares Outstanding | 266.43 M | |||
| Shares Owned By Insiders | 21.11 % | |||
| Shares Owned By Institutions | 12.17 % | |||
| Price To Earning | (2.21) X | |||
| Price To Book | 2.31 X | |||
| Price To Sales | 74.39 X | |||
| Revenue | 6.5 M | |||
| Gross Profit | (28.5 M) | |||
| EBITDA | (61.7 M) | |||
| Net Income | (69.3 M) | |||
| Cash And Equivalents | 59 M | |||
| Cash Per Share | 0.65 X | |||
| Total Debt | 800 K | |||
| Debt To Equity | 8.80 % | |||
| Current Ratio | 5.78 X | |||
| Book Value Per Share | 0.75 X | |||
| Cash Flow From Operations | (59.7 M) | |||
| Earnings Per Share | (0.29) X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 31 | |||
| Beta | 0.85 | |||
| Market Capitalization | 559.51 M | |||
| Total Asset | 270.6 M | |||
| Retained Earnings | (175 M) | |||
| Working Capital | 55 M | |||
| Current Asset | 61 M | |||
| Current Liabilities | 6 M | |||
| Net Asset | 270.6 M |
About Episurf Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Episurf Medical AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Episurf Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Episurf Medical AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Episurf Stock
Episurf Medical financial ratios help investors to determine whether Episurf Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Episurf with respect to the benefits of owning Episurf Medical security.